Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Humabiologics is a regenerative medicine company that produces human-derived biomaterials from donated human tissues for use in regenerative medicine research and drug discovery. It supplies these biomaterials to scientists and researchers, manufacturing under FDA, ISO, and cGMP standards.
0 investors
Human Continuum Inc. is a healthcare company focused on sports medicine, regenerative medicine, and musculoskeletal health services led by experienced clinical physicians and researchers.
0 investors
HumanImage develops standardized 3D imaging technology to capture and analyze human anatomy for early detection of skin and breast cancers and to support medical research on anatomic predetermination. The company serves clinical and research institutions with precision medical imaging devices and analysis.
0 investors
Hunterian Medicine develops a CRISPR delivery technology using adeno-associated viruses to enable in vivo gene editing for treating genetic diseases. The company targets rare genetic disorders including cystic fibrosis, muscular dystrophy, and ALS, where existing treatments remain unavailable for the vast majority of cases.
0 investors
HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner. The company serves surgeons and hospitals across multiple medical specialties seeking improved surgical outcomes.
0 investors
Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.
0 investors
Hyprevention develops STRUTPLASTY, a technology combining PEEK implantable devices with PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. The products are designed to treat fractures and help prevent new ones.
0 investors
A company whose science team focuses on functional coatings, hybrid nanomaterials, controlled drug release, and bio-based polymer composites for biomedical engineering applications. The page presents only leadership information without detailing the company's specific products.
0 investors
IC Surgical develops the Interi System, a medical technology that uses negative pressure and internal conduits to improve surgical outcomes by reducing tissue damage and complications. The system targets plastic surgery, general surgery, orthopedic procedures, and other surgical specialties, with plans for future non-surgical applications.
0 investors
ImageProVision develops imaging-based analysis software for particle characterization, microbial enumeration, thermal analysis, and packaging inspection used by pharmaceutical, biotech, and industrial laboratories. The CLAIRITY suite provides automated and AI-powered tools for microscopy analysis across regulated manufacturing and research environments.
0 investors
Imago Systems develops Visual Intelligence (VI) image classification technology that processes medical images and converts unstructured image content into structured data for detection and diagnosis. It targets healthcare imaging verticals including mammography, cardiology image analysis, COVID-19 X-ray/ultrasound analysis, contract research organizations, and animal diagnostics, positioning itself as a processing layer for existing imaging equipment and AI systems.
0 investors
ImCare Biotech develops diagnostic biomarkers and therapeutic drugs targeting liver diseases, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The company conducts research and development in molecular biology and tissue cultures.
0 investors
ImmersiveTouch develops a virtual reality platform that converts patient CT and MRI scan data into interactive 3D simulations of individual patient anatomy for clinicians. The company serves surgeons and healthcare providers with tools for surgical planning, simulation, and training in support of personalized medicine.
0 investors
ImmunoMet Therapeutics is a clinical-stage oncology drug developer working to advance lixumistat, a compound targeting oxidative phosphorylation in cancer to address resistance to existing treatments. Founded in 2015 as a spin-off from HanAll Biopharma, the company runs its clinical programs with specialist CROs and partners, including trials at MD Anderson Cancer Center.
0 investors
Implicit BioScience develops therapeutic approaches targeting cardioimmunology, specifically using CD14 blockade to modulate immune responses in acute heart attack (STEMI) treatment. The company's work is validated through peer-reviewed research in leading cardiology journals.
0 investors
Imricor develops MRI-guided cardiac electrophysiology products, including the Vision-MR ablation and diagnostic catheters, the NorthStar Mapping System, and the Advantage-MR EP Recorder/Stimulator, used to perform catheter ablation procedures under real-time MRI. The company's devices are targeted at cardiac electrophysiology labs, with several products holding CE mark and some FDA clearance.
0 investors
Imvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
0 investors
IndeeLift makes medical patient lift devices that raise a fallen person from the floor to a seated or standing position and assist with day-to-day transfers to chairs, couches, commodes, and exercise equipment. The devices are used in homes, assisted living centers, by healthcare professionals, and by emergency medical services to reduce manual lifting and support safe patient handling.
0 investors
Indio Surgery Center (ISC) is a certified pediatric surgery center that performs children's dental procedures using a four-person surgical team including a dentist, anesthesiologist, registered nurse, and surgical assistant. It focuses on safe, monitored surgical care for children.
0 investors
ID Connect provides access to specialized infectious disease (ID) expertise through a team of clinicians and technology staff, using telemedicine to improve patient care and outcomes.
0 investors
InGeneron develops regenerative cell therapies that use a patient's adult stem cells and other regenerative cells harvested from fat or bone marrow to treat specific injuries. The company focuses on developing FDA-approved therapies through clinical trials and research in the regenerative medicine field.
0 investors
Injectsense develops implant-based digital health systems that use semiconductor technology to provide medical staff with continuous long-term monitoring data for therapy management, with an ophthalmology focus including eye-pressure markers. The company combines ultra-low power IC design, telemetry, and miniaturization with medical device and software expertise.
0 investors
InkSpace Imaging develops MRI coil technology and patient-centered diagnostic imaging solutions, drawing on expertise in MRI coil design, medical device manufacturing, and regulatory compliance. The company serves the healthcare/medical imaging market.
0 investors
Innova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
0 investors